Crossvault Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $400K | Sell |
7,353
-1,000
| -12% | -$54.4K | 0.16% | 58 |
|
|
2022
Q1 | $455K | Hold |
8,353
| – | – | 0.15% | 55 |
|
|
2021
Q4 | $460K | Buy |
8,353
+260
| +3% | +$14.3K | 0.14% | 56 |
|
|
2021
Q3 | $387K | Hold |
8,093
| – | – | 0.12% | 59 |
|
|
2021
Q2 | $406K | Sell |
8,093
-1,040
| -11% | -$52.2K | 0.12% | 58 |
|
|
2021
Q1 | $407K | Sell |
9,133
-280
| -3% | -$12.5K | 0.15% | 60 |
|
|
2020
Q4 | $433K | Hold |
9,413
| – | – | 0.16% | 53 |
|
|
2020
Q3 | $443K | Hold |
9,413
| – | – | 0.19% | 55 |
|
|
2020
Q2 | $480K | Hold |
9,413
| – | – | 0.22% | 50 |
|
|
2020
Q1 | $446K | Hold |
9,413
| – | – | 0.25% | 52 |
|
|
2019
Q4 | $553K | Sell |
9,413
-50
| -0.5% | -$2.94K | 0.24% | 56 |
|
|
2019
Q3 | $505K | Buy |
9,463
+490
| +5% | +$26.1K | 0.24% | 55 |
|
|
2019
Q2 | $449K | Sell |
8,973
-140
| -2% | -$7.01K | 0.22% | 57 |
|
|
2019
Q1 | $476K | Hold |
9,113
| – | – | 0.25% | 53 |
|
|
2018
Q4 | $435K | Buy |
9,113
+160
| +2% | +$7.64K | 0.25% | 55 |
|
|
2018
Q3 | $450K | Buy |
8,953
+3,940
| +79% | +$198K | 0.23% | 49 |
|
|
2018
Q2 | $253K | Buy |
+5,013
| New | +$253K | 0.13% | 56 |
|